Cargando…
Oncogenes in high grade serous adenocarcinoma of the ovary
High grade serous ovarian cancer is characterized by relatively few mutations occurring at low frequency, except in TP53. However other genetic aberrations such as copy number variation alter numerous oncogenes and tumor suppressor genes. Oncogenes are positive regulators of tumorigenesis and play a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805537/ https://www.ncbi.nlm.nih.gov/pubmed/33488950 http://dx.doi.org/10.18632/genesandcancer.206 |
_version_ | 1783636330666786816 |
---|---|
author | Manasa, Pacharla Sidhanth, Chirukandath Krishnapriya, Syama Vasudevan, Sekar Ganesan, Trivadi S. |
author_facet | Manasa, Pacharla Sidhanth, Chirukandath Krishnapriya, Syama Vasudevan, Sekar Ganesan, Trivadi S. |
author_sort | Manasa, Pacharla |
collection | PubMed |
description | High grade serous ovarian cancer is characterized by relatively few mutations occurring at low frequency, except in TP53. However other genetic aberrations such as copy number variation alter numerous oncogenes and tumor suppressor genes. Oncogenes are positive regulators of tumorigenesis and play a critical role in cancer cell growth, proliferation, and survival. Accumulating evidence suggests that they are crucial for the development and the progression of high grade serous ovarian carcinoma (HGSOC). Though many oncogenes have been identified, no successful inhibitors targeting these molecules and their associated pathways are available. This review discusses oncogenes that have been identified recently in HGSOC using different screening strategies. All the genes discussed in this review have been functionally characterized both in vitro and in vivo and some of them are able to transform immortalized ovarian surface epithelial and fallopian tube cells upon overexpression. However, it is necessary to delineate the molecular pathways affected by these oncogenes for the development of therapeutic strategies. |
format | Online Article Text |
id | pubmed-7805537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-78055372021-01-21 Oncogenes in high grade serous adenocarcinoma of the ovary Manasa, Pacharla Sidhanth, Chirukandath Krishnapriya, Syama Vasudevan, Sekar Ganesan, Trivadi S. Genes Cancer Research Paper High grade serous ovarian cancer is characterized by relatively few mutations occurring at low frequency, except in TP53. However other genetic aberrations such as copy number variation alter numerous oncogenes and tumor suppressor genes. Oncogenes are positive regulators of tumorigenesis and play a critical role in cancer cell growth, proliferation, and survival. Accumulating evidence suggests that they are crucial for the development and the progression of high grade serous ovarian carcinoma (HGSOC). Though many oncogenes have been identified, no successful inhibitors targeting these molecules and their associated pathways are available. This review discusses oncogenes that have been identified recently in HGSOC using different screening strategies. All the genes discussed in this review have been functionally characterized both in vitro and in vivo and some of them are able to transform immortalized ovarian surface epithelial and fallopian tube cells upon overexpression. However, it is necessary to delineate the molecular pathways affected by these oncogenes for the development of therapeutic strategies. Impact Journals LLC 2020-11-11 /pmc/articles/PMC7805537/ /pubmed/33488950 http://dx.doi.org/10.18632/genesandcancer.206 Text en Copyright: © 2020 Manasa et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Manasa, Pacharla Sidhanth, Chirukandath Krishnapriya, Syama Vasudevan, Sekar Ganesan, Trivadi S. Oncogenes in high grade serous adenocarcinoma of the ovary |
title | Oncogenes in high grade serous adenocarcinoma of the ovary
|
title_full | Oncogenes in high grade serous adenocarcinoma of the ovary
|
title_fullStr | Oncogenes in high grade serous adenocarcinoma of the ovary
|
title_full_unstemmed | Oncogenes in high grade serous adenocarcinoma of the ovary
|
title_short | Oncogenes in high grade serous adenocarcinoma of the ovary
|
title_sort | oncogenes in high grade serous adenocarcinoma of the ovary |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805537/ https://www.ncbi.nlm.nih.gov/pubmed/33488950 http://dx.doi.org/10.18632/genesandcancer.206 |
work_keys_str_mv | AT manasapacharla oncogenesinhighgradeserousadenocarcinomaoftheovary AT sidhanthchirukandath oncogenesinhighgradeserousadenocarcinomaoftheovary AT krishnapriyasyama oncogenesinhighgradeserousadenocarcinomaoftheovary AT vasudevansekar oncogenesinhighgradeserousadenocarcinomaoftheovary AT ganesantrivadis oncogenesinhighgradeserousadenocarcinomaoftheovary |